transforms diagnostics by leveraging millions of years of evolutionary development in the immune system, tapping into the power of nature itself.
Seroxo
Seroxo is a world-leading IVD company pioneering the development and commercialisation of a transformative technology. The LIT™, a 10-minute finger-prick blood test, is a patented breakthrough technology that assesses real-time, 3D neutrophil function with applications in cancer, sepsis and emergency triage.
Platform
Unleash it with our app and algorithm platform to make disease diagnosis and monitoring simple.
Applications
LIT™ has been clinically demonstrated in cancer, sepsis and infectious disease.
Resources
The resource hub to learn more about LIT™ and the latest publications and news from Seroxo.
Our Global Partners
Seroxo U.S.A. LLC is pleased to announce a partnership with Bio Nano Consulting (BNC). BNC is supporting development of optimised reagents for Seroxo’s Leukocyte ImmunoTest(TM) (LIT(TM)) platform as well as developing new positive and negative controls for the platform.